Institut Gustave Roussy
Villejuif, Val de Marne, 94805, France
Completed
NCT Number: NCT01786031
Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program
Toward personalised treatment in early metastatic prostate cancer based on the assessment of biomarkers in cancer tissue samples and circulating tumour cells.
Completed
Looking for future studies?
Notify MeKey information
Age range
18 year and older
Sex eligibility
Male
Study type
Interventional
Phase
Not applicable
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Prostate Cancer patients
- Castration Resistant
- Prostatic tissue available
- Metastasis which may be biopsied
Exclusion criteria
Treatment and study plan
metastasis biopsy
OtherPrimary outcomes
-
Biomarker
Time frame: assessed at the end of recruitment, up to 2 years
success to evaluate at least one molecular analysis in tumor tissues (prostate and/or metastatic site) AND in CTC
Sponsors and collaborators
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Other
Registry information
Acronym: PETRUS
Important dates
- Study start
- 2012
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- Feb 7, 2013
- Registry last updated
- Feb 8, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.